APA (7th ed.) Citation

EL, T., JT, R., NRPW, H., KPC, K., SW, T., MA, N., . . . JG, R. (2022). Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): Implications for psychosis. Psychopharmacology, 239(5), 1251. https://doi.org/10.1007/s00213-021-05768-0

Chicago Style (17th ed.) Citation

EL, Theunissen, Reckweg JT, Hutten NRPW, Kuypers KPC, Toennes SW, Neukamm MA, Halter S, and Ramaekers JG. "Psychotomimetic Symptoms After a Moderate Dose of a Synthetic Cannabinoid (JWH-018): Implications for Psychosis." Psychopharmacology 239, no. 5 (2022): 1251. https://doi.org/10.1007/s00213-021-05768-0.

MLA (9th ed.) Citation

EL, Theunissen, et al. "Psychotomimetic Symptoms After a Moderate Dose of a Synthetic Cannabinoid (JWH-018): Implications for Psychosis." Psychopharmacology, vol. 239, no. 5, 2022, p. 1251, https://doi.org/10.1007/s00213-021-05768-0.